Fenwick-Led Attovia Therapeutics Prices Upsized $289M IPO
By Jade Martinez-Pogue · August 5, 2026, 4:58 PM EDT
Early-stage biotechnology company Attovia Therapeutics hit the public markets on Wednesday after it raised $289 million in its upsized initial public offering....
To view the full article, register now.